EMAV – the Association of European Manufacturers of Autogenous Vaccines and Sera is representing the leading European producers of autogenous vaccines and sera.
EMAV combines the interests of manufacturers of specific vaccines and sera for farm, companion and exotic animals, to promote the European harmonization process.
Autogenous vaccines and sera are an important and well-established tool of veterinary medicine to fill the gaps left by licensed vaccines and sera in all categories of animals, contributing also to the survival of minor species by protecting them against life-threatening infectious diseases. In addition, autogenous vaccines are seen as life-sustaining measure against rare infectious diseases. The prophylactic use of our vaccines are also key to the successful reduction of use of antimicrobial substances and the need for pharmaceutical treatments in general, for the improvement of animal welfare by science-based prophylactic measures and to the protection of the environment at the same time.
IABS-EU and EMAV Workshop - Meeting rescheduled - New date: March 16-18, 2021 *REGISTER NOW*